Drug Approval | October 06, 2021
WHO decision on Covaxin approval next week
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
If approved it will bring a second source of MMR vaccine to the US market
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
India produces 60% of the world’s vaccine
Subscribe To Our Newsletter & Stay Updated
